Astellas Pharma Inc (OTCPK:ALPMF)
$ 11.6601 0 (0%) Market Cap: 21.76 Bil Enterprise Value: 25.64 Bil PE Ratio: 176.87 PB Ratio: 1.92 GF Score: 75/100

Astellas Pharma Inc. Corporate Strategic Plan Presentation Transcript

May 26, 2021 / NTS GMT
Release Date Price: $15.45

May 26, 2021 / NTS GMT
Presentation
May 26, 2021 / NTS GMT

=====================
Corporate Participants
=====================
* Bernhardt G. Zeiher
Astellas Pharma Inc. - Chief Medical Officer & President of Development
* Kenji Yasukawa
Astellas Pharma Inc. - President, CEO & Representative Director
* Naoki Okamura
Astellas Pharma Inc. - Corporate Executive VP, CFO, Chief Strategy Officer & Representative Director

=====================
Conference Call Participants
=====================
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Seiji Wakao
JPMorgan Chase & Co, Research Division - VP
* Shinichiro Muraoka
Morgan Stanley, Research Division - Research Analyst
* Tatsuyuki Arai
BofA Securities, Research Division - Junior Analyst

=====================

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot